Atlas Trials

Myelofibrosis，MF

27 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Myelofibrosis，MF

RecordFirmDate
Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms (NCT06798805)IRCCS Azienda Ospedaliero-Universitaria di Bologna2022-02-15
Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative (NCT05153343)Chengdu Zenitar Biomedical Technology Co., Ltd2021-12-27
Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors (NCT05115344)Guizhou Bailing Group Pharmaceutical Co Ltd2021-11-12
Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis (NCT04480086)AbbVie2021-03-17
Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis (NCT04454658)AbbVie2020-11-11
Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis (NCT04468984)AbbVie2020-08-31
A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis (NCT03222609)AbbVie2017-10-31
Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms (NCT01816256)University Health Network, Toronto2013-05-01
Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF) (NCT01211691)Humanigen, Inc.2010-09-01
Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders (NCT01224496)Singapore General Hospital2009-07-01

Track Myelofibrosis，MF automatically

Every clearance here is in the API, with alerts when new ones post.